MH2: EFFICACY OF NURSE TELEHEALTH CARE AND PEER SUPPORT IN AUGMENTING TREATMENT OF DEPRESSION IN PRIMARY CARE  by Hunkeler, EM et al.
Abstracts 413
bacteremia, pneumonia, and otitis media, but costs more
than previously introduced vaccines. We determined the
savings in medical costs over 36 months of life attribut-
able to the use of the vaccine in healthy infants in a large
randomized trial.
METHODS: We analyzed the actual costs and utilization
for 36,471 children involved in a randomized trial of the
heptavalent pneumococcal conjugate vaccine conducted
in the Northern California Kaiser Permanente Medical
Care Program (KP). Costs were analyzed for all children
randomized in the trial (intent-to-treat) who were mem-
bers of the health plan at any time during the follow-up.
All clinic- and pharmacy-related costs were included, as
were those hospital costs associated with conditions
deemed to be potentially pneumococcal related. The cost
of the vaccine and vaccine administration were excluded.
Confidence intervals around cost savings were calculated
using bootstrap replications.
RESULTS: Compared with the control group, the vacci-
nated group incurred $78 less in medical costs (CI: $5 to
$158) per child during the first 36 months of life, exclu-
sive of the cost of the vaccine. This represented savings of
about 3% of total medical costs for these children during
that time period.
CONCLUSION: The pneumococcal conjugate vaccine
reduced medical costs in children in the first 36 months
of life, before factoring in the cost of the vaccine and vac-
cine administration. These cost savings, however, are un-
likely to offset the cost of the vaccine at its current price.
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OBJECTIVES: To establish the concurrent and discrimi-
natory validity, and relative item importance of the previ-
ously developed client-centered, 51-item Schizophrenia
Outcomes Assessment Project (SOAP-51) survey, a self-
administered, health-related quality of life instrument for
individuals with schizophrenia living in the community.
METHOD: We asked 1500 community-based clients
with schizophrenia, and 150 of their caregivers (using the
shortened objective version), in five ethnically and geo-
graphically diverse areas within the US to complete the
SOAP-51 four times over a three-month period; client re-
tention was 84.2%. Average age was 42.8 years, 60%
males. For concurrent validation, clients rated the impact
of their condition on each of SOAP-51’s eight factors;
this was compared to their factor score. For discriminate
validity, the caregivers assigned clients to one of four
quartiles describing their perception of the client’s ability
to objectively function in each factor area. Client factor
scores were compared to caregiver-reported functional
levels. An additional 300 clients rated the relative impor-
tance of each item.
RESULTS: Cronbach’s alpha for the eight factors was
0.71–0.88, test-retest reliability, 0.78–0.99. Client factor
scores lowered as clients felt the condition had more neg-
atively impacted on their lives (p  .001). Client factor
scores improved with improving caregiver-perceived as-
sessment of client functionality (p  .001). Client scores
from the lowest to highest assigned quartile had average
scores of 42.7%, 49.3%, 54.7%, and 60.0%, respec-
tively. Ninety two percent of both clients and caregivers
considered the survey valuable for monitoring client
progress. No significant difference (p  .05) was ob-
served in importance weights for the eight factors, or 51
items, age or gender of client, caregiver or client re-
sponses.
CONCLUSIONS: Concurrent and discriminatory valid-
ity show that the SOAP-51 meets psychometric charac-
teristics for use as a client-centered outcomes measure in
patient monitoring and management, and health policy
decision-making.
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OBJECTIVES: Because clinical outcomes of depression
treatment in primary care settings tend to be poor, we de-
veloped and evaluated the efficacy of two augmentations
to antidepressant treatment to be delivered by primary
care nurses.
METHODS: We conducted a randomized trial compar-
ing usual care, telehealth care, and telehealth care plus
peer support for depressed patients seen in primary care
in an HMO setting. Assessments were conducted at base-
line, six weeks and six months after study enrollment at
two managed-care, adult primary-care clinics. Partici-
pants included 303 patients recently started on antide-
pressants. The intervention consisted of: telehealth care;
emotional support and focused behavioral interventions
in 10 seven-minute calls over four months by specially
trained primary-care nurses and peer support; telephone
and in-person supportive contacts by trained Health Plan
members recovered from depression. Primary outcome
measures were the Hamilton Rating Scale for Depression,
Beck Depression Inventory, Mental and Physical Func-
tioning (Short Form 12), and treatment satisfaction and
medication adherence questionnaires.
RESULTS: Nurse-based telehealth patients with or with-
out peer support more often experienced 50% improve-
ment on the Hamilton at six weeks (50% vs. 37%, P 
.01) and six months (57% vs. 38%, P  .003), and on
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the Beck at six months (48% vs. 37%, P  .05). Greater
quantitative reduction in symptom scores on the Hamil-
ton at six months (10.4 vs. 8.1, P  .006) were observed.
Telehealth care improved mental functioning at six weeks
(47.1 vs. 42.6, P  .004) and treatment satisfaction at six
weeks (4.41 vs. 4.17, P  .004) and six months (4.20 vs.
3.94, P  .001). Medication adherence was the same in
all groups and adding peer support to telehealth care did
not improve the main outcomes.
CONCLUSION: Nurse Telehealth Care improves clinical
outcomes of antidepressant treatment, improves patient
satisfaction, and fits well in primary care. The nurse tele-
health care program has been implemented in Maine,
Ohio and Southern California.
MH3
RECENT WEIGHT GAIN AND THE COST OF 
ACUTE SERVICE USE AMONG INDIVIDUALS 
WITH SCHIZOPHRENIA
Weiden PJ1, Mackell JA2, McDonnell DD3
1SUNY Health Sciences Center at Brooklyn, Brooklyn, NY, 
USA; 2Pfizer Pharmaceuticals Group, Pfizer, Inc, New York, NY, 
USA; 3Consumer Health Sciences, Princeton, NJ, USA
OBJECTIVE: Newer antipsychotics have been associated
with increased weight gain. There is also mounting evi-
dence that this leads to noncompliance and a lower qual-
ity of life. Gaining weight is also undesirable for health
reasons and may lead to increased use of health-care re-
sources. This study considers the association between
weight gain and acute service use for patients with
schizophrenia.
METHODS: Questionnaires were mailed to people with
schizophrenia identified through National Alliance for
the Mentally Ill and the National Mental Health Associa-
tion in spring 2000 (n  390). Data presented here are
from the 345 respondents who reported weight loss (n 
94, 27%), no weight change (n  106, 31%), some
weight gain (1–14lbs; n  70, 20%), and significant
weight gain (15lbs; n  75, 22%) within the last six
months. Acute service use was defined as emergency
room (ER) visit or hospitalization. Cost values were
those reported in Ernst and Hay (1994). For each individ-
ual, total costs were computed by summing across cate-
gories.
RESULTS: The group reporting significant weight gain
was significantly more likely to use acute services than
the other three groups (p  .001 for hospitalization, p 
.005 for ER visit). The association remained significant
when controlling for other variables in multivariate anal-
yses, including age, gender, ethnicity, and overall distress.
Overall costs were highest for those who gained 15 or
more pounds ($9,486). Those who lost weight incurred
costs of $7,400, those who did not change weight in-
curred costs of $4,095, and those who gained 1–14
pounds incurred costs of $3,647.
DISCUSSION: Our preliminary results suggest that re-
cent weight gain is associated with greater use of acute
services and higher costs. There are several plausible ex-
planations. For example, physicians might change medi-
cations for people doing poorly (e.g., start a new medica-
tion after an acute psychiatric episode). Another possibility
is that acute medical services are more likely to be needed
after an episode of rapid weight gain.
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OBJECTIVE: To predict Health State Values (HSV) from
health-related quality of life (HRQL) assessments could,
if possible, be a fruitful way to use HRQL values for
health-economic evaluations. With this in mind, we in-
vestigated to what degree values from the EuroQol in-
strument, the EQ-5D index, and the EQ-VAS visual ana-
log scale, could be predicted using HRQL measures for
patients with respiratory diseases.
METHODS: Data from two surveys of patients with res-
piratory disease were used for this evaluation. The first
data set was from 206 patients in Hungary suffering from
asthma, and the other was from 120 patients in the
northern part of Sweden with COPD. Both surveys in-
cluded patients with different severities of the diseases.
The HRQL instruments used in both surveys were the SF-
36, a generic instrument, and St George’s Respiratory
Questionnaire (SGRQ), a disease-specific instrument. The
two data sets were analyzed separately using a multiple
logistic regression model in a stepwise manner to predict
EQ-5D and EQ-VAS from the eight domains of SF-36 and
the three domains of SGRQ, after transformation of EQ-
5D and EQ-VAS to a 0–1 range.
RESULTS: The amount of variation in both the EQ-5D
and EQ-VAS that could be explained from the combined
HRQL measures was at most 56%. EQ-5D had larger
values than EQ-VAS. Using SF-36 domains only as pre-
dictors gave marginally lower values. The two domains
from SF-36 with best predictability explained about 90%
of the reduction achieved with all 11 domains together
from the two HRQL-measures, indicating correlation be-
tween the different domains.
CONCLUSION: Values for EQ-5D and EQ-VAS pre-
dicted from SF-36 and SGRQ have moderate precision
and should be used cautiously.
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